Direct Oral Anticoagulants: Competition Brought No Cost Relief
Medicare Part D spending for oral anticoagulants has risen by almost 1,600% since 2011, while the number of users has increased by just 95%, according to a new study.
Related Articles
Fever, Under 5s: Assessment and Management
A summary of the 2021 updated NICE guideline on fever in under 5s, with a ‘traffic light’ approach to assessing risk and features of specific…
AI Surpasses Harvard Docs on Clinical Reasoning Test
A chatbot had more instances of incorrect reasoning than doctors did but scored higher overall.
Mar 1 2024 This Week in Cardiology
The Western AF meeting, aspirin, cannabis use, LVEF in athletes, and shared decision making before ICD implantation are the topics John Mandrola, MD, discusses in…
Don’t Miss the Dx: PIK3CA-Related Overgrowth Spectrum (PROS)
Learn more with this brief guide to the presentation, differential diagnosis, and management of this rare genetic disorder.
Diverticular Disease: Diagnosis and Management
This concise guideline summary covers the diagnosis and management of diverticular disease in people aged 18 years and over
PROS: Early Diagnosis and New Therapeutic Options
New therapeutic options are available for PIK3CA-related overgrowth spectrum, a range of disorders most commonly seen in children and often difficult to diagnose.
Adverse Pregnancy Outcomes Linked to Premature Mortality for Moms
The findings show a need for better care of previously pregnant patients, years after giving birth.
Diabetes: Diabetic Foot Problems
This summary covers preventing and managing foot problems in children, young people, and adults with diabetes. It aims to reduce variation in practice, including antibiotic…
Too Little Sleep Raises Health Risks for Teens With T1D
Sleeping for more than 7 hours at night may improve cardiometabolic health in patients with type 1 diabetes, especially teenagers, showed an analysis.
Earlier Inclisiran Gives Better Long-Term LDL Reductions
Results of VICTORION-INITIATE study suggest better results with inclisiran first and highlight “stunning undertreatment” of cholesterol in usual care of patients with CVD.